Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas
Sibille Everhard(Assistance Publique – Hôpitaux de Paris), Joëlle Thillet, Emmanuelle Crinière(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Marta Gut(Centro Nacional de Análisis Genómico), Jörg Tost(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Marc Sanson(Hôpital Rangueil), Florence Busato(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Hafida El abdalaoui(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Karima Mokhtari(Inserm), Florence Laigle–Donadey(Assistance Publique – Hôpitaux de Paris), Yannick Marie(Assistance Publique – Hôpitaux de Paris), Jean‐Yves Delattre(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Khê Hoang‐Xuan(Pitié-Salpêtrière Hospital)
Cited by 179
Related Papers
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial
|The Lancet|2005|1k
DNA Methylation in Newborns and Maternal Smoking in Pregnancy: Genome-wide Consortium Meta-analysis
|The American Journal of Human Genetics|2016|921
DNA methylation analysis by pyrosequencing
|Nature Protocols|2007|623
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20
|European Journal of Cancer|2005|576